98 related articles for article (PubMed ID: 4126098)
1. Pyrimethamine in central-nervous-system leukaemia.
Price LA
Lancet; 1973 Jun; 1(7815):1315. PubMed ID: 4126098
[No Abstract] [Full Text] [Related]
2. Pyrimethamine in central-nervous-system leukaemia.
Ragab AH
Lancet; 1973 May; 1(7811):1061. PubMed ID: 4122138
[No Abstract] [Full Text] [Related]
3. Letter: Pyrimethamine in central-nervous-system leukaemia.
Carrera Boadella A; Pla Illa RP
Lancet; 1973 Dec; 2(7841):1330. PubMed ID: 4127678
[No Abstract] [Full Text] [Related]
4. Management of CNS leukemia in childhood. An outline of current concepts.
Pochedly C
Clin Pediatr (Phila); 1972 Sep; 11(9):503-8. PubMed ID: 5073799
[No Abstract] [Full Text] [Related]
5. Letter: Pyrimethamine in prophylaxis of meningeal leukaemia.
Hamers J; van Hove W; Baele G
Lancet; 1974 Feb; 1(7852):310-1. PubMed ID: 4130488
[No Abstract] [Full Text] [Related]
6. Severe megaloblastic anemia complicating pyrimethamine therapy.
Chute JP; Decker CF; Cotelingam J
Ann Intern Med; 1995 Jun; 122(11):884-5. PubMed ID: 7741386
[No Abstract] [Full Text] [Related]
7. [Daraprim in leukemia of the central nervous system in children].
Armata J; Wyszkowski J; Krop J
Pol Tyg Lek; 1972 Nov; 27(48):1895-7. PubMed ID: 4645473
[No Abstract] [Full Text] [Related]
8. [Pharmacokinetics and intraventricular therapy with methotrexate via Ommaya reservoir for central nervous system leukemia (author's transl)].
Fujimoto T; Sasaki K; Shingaki Y; Fukui M; Kitamura K
Rinsho Ketsueki; 1980 Mar; 21(3):320-7. PubMed ID: 7411871
[No Abstract] [Full Text] [Related]
9. Toxoplasmosis of the central nervous system.
Meredith JT
Am Fam Physician; 1987 May; 35(5):113-6. PubMed ID: 3577983
[TBL] [Abstract][Full Text] [Related]
10. [Long-term follow up of central nervous system leukemia in children (author's transl)].
Yokoyama T; Fujimoto T; Ito M; Furusho K; Kin H; Hasegawa A
Rinsho Ketsueki; 1979 Mar; 20(3):246-52. PubMed ID: 439414
[No Abstract] [Full Text] [Related]
11. Central nervous system leukemia.
Bergevin PR
N Y State J Med; 1975 Feb; 75(3):367-71. PubMed ID: 1094335
[No Abstract] [Full Text] [Related]
12. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)].
Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H
Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683
[No Abstract] [Full Text] [Related]
13. [Treatment of leukemic manifestations in the central nervous system].
Styri OB
Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2237-8. PubMed ID: 4439381
[No Abstract] [Full Text] [Related]
14. [Experience with the treatment of central nervous system involvement in leukemia in adults].
Sedlácková M; Cermák J; Lukásová M; Chudomel V
Vnitr Lek; 1985 Nov; 31(11):1075-80. PubMed ID: 4072028
[No Abstract] [Full Text] [Related]
15. Dexamethasone. Its effectiveness in the treatment of the acute symptoms of meningeal leukemia.
Mitus A
Am J Dis Child; 1969 Mar; 117(3):307-12. PubMed ID: 5765148
[No Abstract] [Full Text] [Related]
16. Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
Lancet; 1973 Mar; 1(7805):727. PubMed ID: 4120530
[No Abstract] [Full Text] [Related]
17. Central nervous system leukemia in childhood.
Sembiring R
Paediatr Indones; 1977; 17(7-8):274-80. PubMed ID: 927864
[No Abstract] [Full Text] [Related]
18. Proceedings: Prognosis in central nervous system leukemia.
Sullivan MP
Proc Natl Cancer Conf; 1972; 7():593-9. PubMed ID: 4764928
[No Abstract] [Full Text] [Related]
19. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
20. Current pharmacological treatment approaches to central nervous system leukaemia.
Blaney SM; Balis FM; Poplack DG
Drugs; 1991 May; 41(5):702-16. PubMed ID: 1712705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
